TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
GRAL

GRAIL, LLC

Healthcare · Diagnostics & Research

108.50$ +0.5% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow GRAL
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – –
– -26.8% -26.6% +672.9% +164.8% +2.5% -0.4% -1.1%
– +157.1% +62.0% +1,382.7% -88.9% +28.4% -11.5% -32.3%
– -199.0% – +25.4% -167.0% – -414.4% –
– -79.2% +257.3% +487.4% -67.3% -43.6% -59.6% -82.5%
– – -109.6% – -106.6% -43.6% +4,175.7% -84.6%
– -7.4% – – +2,360.6% -94.4% – –
– -46.7% +71.6% +43.5% +53.2% -23.3% +168.3% -66.0%
– – -36.4% -571.8% – -818.3% – -66.3%
– – – – – – – –

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?